Atenolol, nadolol, and pindolol in angina pectoris on effort: Effect of pharmacokinetics

This publication has 13 references indexed in Scilit:

• Treatment of angina pectoris with pindolol: The significance of intrinsic sympathomimetic activity of beta blockers
  American Heart Journal, 1982
• Clinical Relevance of Intrinsic Sympathomimetic Activity of Beta Blockers Used in Angina
  Angiology, 1981
• Atenolol: once-daily cardioselective beta blockade for angina pectoris.
  Circulation, 1980
• Comparison of five beta-adrenoreceptor antagonists with different ancillary properties during sustained twice daily therapy in angina pectoris
  The American Journal of Medicine, 1980
• Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 6. A comparison of pindolol and propranolol in treatment of patients with angina pectoris. The role of intrinsic sympathomimetic activity
  American Heart Journal, 1979
• Atenolol
  Drugs, 1979
• Comparison of the new beta-adrenoceptor antagonist, nadolol, and propranolol in the treatment of angina pectoris
  Current Medical Research and Opinion, 1978
• The effect on blood pressure of beta‐adrenoceptor blocking drugs administered once daily and their duration of action when therapy is ceased.
  British Journal of Clinical Pharmacology, 1976
• Reproducibility of a Multi-Stage Near Maximal Treadmill Test for Exercise Tolerance in Angina Pectoris
  Circulation, 1973
• Relation of Heart Rate and Systolic Blood Pressure to the Onset of Pain in Angina Pectoris
  Circulation, 1967